Home › Medication lookup › Genes › SLCO1B1
SLCO1B1

Drugs affected by SLCO1B1

Solute Carrier Organic Anion Transporter 1B1

7 medications 8 brand products

About SLCO1B1

SLCO1B1 is the transporter that moves statins into liver cells where they work. A common variant (called *5) reduces transporter function and leaves more statin circulating in the bloodstream and muscle tissue.[1] That's directly linked to statin-associated muscle pain and, rarely, more serious muscle damage.[2]

People with reduced SLCO1B1 function are at higher risk of statin myopathy, especially on simvastatin and high-dose atorvastatin. Dose reduction or switching statin usually resolves it.[3]

What we test for SLCO1B1

Gene2Rx uses definitions covering 36 named SLCO1B1 star alleles, built from 29 variants in Gene2Rx definitions. Results depend on the variants available in your upload.

36
Star alleles
29
Defined variants
Gene2Rx definitions
Source
GRCh38
Genome build
Normal Function 2 Increased Function 3 Decreased Function 8 Possible Decreased Function 4 Unknown or Uncertain Function 19

Notable SLCO1B1 alleles

*1A Normal Function
Reference allele — normal SLCO1B1 transporter activity.
*5 Decreased Function
A decreased-function allele defined by rs4149056 (c.521T>C); raises statin exposure and myopathy risk.
~15% in Europeans
*15 Decreased Function
A decreased-function haplotype carrying the *5 variant; same statin-myopathy implications.
What are star alleles?

Star alleles (like *1, *2, *4) are standardized names for distinct versions of a pharmacogene. *1 is the reference; other numbers identify distinct allele definitions. A higher number does not mean lower function.

You inherit one allele from each parent, so your genotype is a pair (e.g. *1/*4). The pair determines your predicted phenotype — for example, whether you metabolize a drug at a normal, decreased, or no-function rate.

PharmVar is the international registry that defines and curates these allele names. Gene2Rx uses the supported definitions summarized here. Coverage depends on the variants present in your input; this is not a guarantee that every cataloged allele can be identified.

Medications with SLCO1B1 information

This list contains 7 medications with SLCO1B1 information from the sources shown below. Evidence and report eligibility differ by drug; each page explains its scope and limitations.

Brand products containing a SLCO1B1-affected ingredient

These branded medications include at least one active ingredient whose metabolism or action involves SLCO1B1. Each links to its full pharmacogenetic breakdown.

References

  1. CPIC. CPIC Guideline for Statins and SLCO1B1, ABCG2, and CYP2C9 (2022). cpicpgx.org
  2. U.S. Food and Drug Administration. Table of Pharmacogenomic Biomarkers in Drug Labeling (2024). fda.gov
  3. PharmGKB / Stanford University. PharmGKB: The Pharmacogenomics Knowledge Base. pharmgkb.org

Explore SLCO1B1 in your report

A Gene2Rx report interprets supported variants in the context of your data and purchased report. Missing or uncertain calls may prevent an assessment.

Get your report Look up a medication

Informational only, not medical advice. The presence of a SLCO1B1 pharmacogenetic guideline does not mean every patient needs to change their dose. Never start, stop, or change a medication without talking to your prescribing clinician.

Get Your Report Now
Ready in One Minute